With respect to AhR signaling, it is not known whether microbiota-derived metabolites induce the RAS-dependent constriction of microvessels and cause local hypoperfusion or whether AhR antagonists would be of any benefit in combatting AD pathogenesis. The gene discussed is AHR; the disease is Alzheimer disease.